UK Intelligence Chief Warns Time Running Out to Confront RussiaChina Threats Geopolitical Risks for Global Markets 73YearOld With 15 Million 401k May Face 280000 Cumulative RMD Tax Bill Biotech Stocks Face Headwinds but TopTier Names Show Resilience Standard Chartered to Cut Over 15 of Corporate Functions Roles by 2030 in Efficiency Drive Global Oil Supply Disruptions Reshape Energy Demand Patterns Nuclear Verdict Alert 50M Jury Award Against Texas Trucking Company Raises Industry Concerns Voyager Therapeutics Q1 2026 Earnings EPS Beats Estimates as Stock Rises Amid Pipeline Progress DOC Q1 2026 Earnings Massive EPS Surprise Highlights Strong Portfolio Management Amphastar Pharmaceuticals AMPH Q1 2026 Earnings Significant EPS Miss Fails to Dampen Stock Sentiment IBP Q1 2026 Earnings Earnings Miss Prediction Despite Positive Stock Reaction MVB Financial Corp Q1 2026 Earnings Earnings Beat Expectations Amid Revenue Uncertainty InnovAge Q1 2026 Earnings Deep EPS Miss Sends Shares Lower Allspring Income Opportunities Fund EAD Inches Up as Support Holds Steady PureTech Health PRTC Holds Flat at 1725 as Biotech Sector Awaits Clear Direction Fortis Inc FTS Edges Higher as Utility Sector Seeks Direction Wealthfront Gains Ground WLTH Tests Key Resistance Levels H World Group HTHT Shares Rise 185 as Hospitality Sector Shows Renewed Strength Jeff Bezos Proposes Eliminating Federal Income Tax for Certain Americans DFLI Q1 2026 Earnings WiderthanExpected Loss Reflects Continued RD Investment RiverNorth Flexible Municipal Income Fund RFM Holds Steady Near 1437 Amid Flat Trading Session Beta Bionics BBNX Surges 114 as Bullish Momentum Tests Key Resistance at 1241 Nano Dimension NNDM Nears Support Amid Slight Decline Key Levels in Focus Pantages Capital Acquisition Right PGACR Holds at 021 Low Volatility Persists for SPAC Right FutureCrest Acquisition Corp FCRS Holds Steady at 1022 as Market Awaits Catalyst Star Equity Holdings Preferred Shares STRRP Holds Steady Near 10 Support Zone Graham Corporation GHM Holds Steady at 100 as Consolidation Narrows Enanta Pharmaceuticals ENTA Edges Higher Testing Resistance Near 1465